Metro Healthcare Indonesia Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.23T, 109K 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp91 (market cap 500.81B, 1.08M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 28.4× Saraswanti Indoland Development Tbk.'s market cap, and Saraswanti Indoland Development Tbk. is more actively traded (1.08M versus 109K). Which is the better fit depends on your goals.
| CARE | SWID | |
|---|---|---|
Market Cap | 14.23T | 500.81B |
Volume | 109K | 1.08M |
Lot | 1.09K | 10.8K |
Turnover | 46.56M | 97.48M |
Average Price | 427.15 | 90.3 |
Value | 46.56M | 97.48M |
Indicative Equilibrium Price | 428 | 93 |
Indicative Equilibrium Volume | 400 | 53.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →